clopidogrel | Page 4 of 6

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 28 November, 2025 0

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 27 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 26 November, 2025 0

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: clopidogrel

What Antiplatelet Therapy Should We Use in Patients with Stroke/TIA? Interesting...

Elderly Patients with ACS: Clopidogrel or Reduced-Dose Prasugrel?

ACC 2018 | SMART-DATE: 6 Month DAPT Results Suboptimal in ACS

What Is the Best Antiplatelet Therapy in Primary Angioplasty at 12 Months?

Clinical and Economic Costs Compete in the De-Escalation of Antiplatelet Therapy

Clopidogrel or Ticagrelor in Patients with Acute Coronary Syndrome Treated with...

When and How to Switch Dual Antiplatelet Therapies

Dual antiplatelet therapy discontinuation causes more thrombotic events at 12 months

Dual Antiplatelet in TAVR: Is Single Better?

ARTE: Aspirin or Aspirin and Clopidogrel after TAVR?

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos